Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00546117 · ClinicalTrials.gov registry record · NA

A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT00546117 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00546117, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study is being done to see if reflux of stomach fluid might be a cause of chronic fluid in the ears. Our hypothesis is that treatment with an anti-reflux medication (lansoprazole) will increase the rate of resolution of chronic middle ear fluid in children.

Interventions

  • DRUG placebo
  • DRUG lansoprazole

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2007-10
Est. Completion 2009-12
Phase NA

What the Registry Record Tells You About NCT00546117

The ClinicalTrials.gov registry entry for NCT00546117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00546117 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00546117 about?

NCT00546117 is a clinical study titled "A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion". This study is being done to see if reflux of stomach fluid might be a cause of chronic fluid in the ears. Our hypothesis is that treatment with an anti-reflux medication (lansoprazole) will increase the rate of resolution of chronic middle ear fluid in children.

What is the current status of trial NCT00546117?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-10. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00546117?

The interventions under investigation include: placebo (DRUG), lansoprazole (DRUG).

Who is sponsoring clinical trial NCT00546117?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.